Investigational Drug Information for Poloxamer 407
✉ Email this page to a colleague
What is the drug development status for Poloxamer 407?
Poloxamer 407 is an investigational drug.
There have been 4 clinical trials for Poloxamer 407.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2011.
The most common disease conditions in clinical trials are Mucositis, Stomatitis, and Periodontitis. The leading clinical trial sponsors are University of Iowa, Ahmed Mohamed Mahrous, and Maha Talaab.
Summary for Poloxamer 407
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,799 |
| WIPO Patent Applications | 1,772 |
| Japanese Patent Applications | 2,126 |
| Clinical Trial Progress | Phase 2 (2011-11-01) |
| Vendors | 35 |
Recent Clinical Trials for Poloxamer 407
| Title | Sponsor | Phase |
|---|---|---|
| Nitazoxanide as a New Local Adjunctive to Nonsurgical Treatment of Moderate Periodontitis | Maha Talaab | Phase 2 |
| Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis | American College of Prosthodontists Education Foundation | Phase 2 |
| Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis | Greater New York Academy of Prosthodontics | Phase 2 |
Clinical Trial Summary for Poloxamer 407
Top disease conditions for Poloxamer 407
Top clinical trial sponsors for Poloxamer 407
US Patents for Poloxamer 407
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
